Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the efficacy of R89674 0.25% ophthalmic solution
compared with placebo in alleviating the signs and symptoms of conjunctival allergen
challenge-induced allergic conjunctivitis